They left Wall Street, Silicon Valley, and the world's top research labs to build companies that could add decades to human life. These are their stories.
"The most dangerous person in healthcare is not a regulator or a competitor. It is a founder who has personally experienced the system's failure."— Vinod Khosla, Khosla Ventures
Raised by longevity-focused startups in 2025
Longevity biotech companies founded since 2020
Longevity unicorns created in the past 24 months
Targeting Aging with Metformin (TAME)
Director, Institute for Aging Research, Albert Einstein College of Medicine
The first FDA-approved clinical trial targeting aging itself — not a disease, but the biological process that causes all disease.
Longevity Fund
Founder & General Partner
The world's first venture fund dedicated exclusively to longevity science, backing companies that target the hallmarks of aging at the molecular level.
Rejuvenate Bio
Professor of Genetics, Harvard Medical School
Using gene therapy to reverse multiple hallmarks of aging simultaneously — the most ambitious anti-aging program in the history of science.
Hevolution Foundation
CEO
Deploying $1 billion annually to fund the most promising aging research globally — the largest philanthropic commitment to longevity science ever made.